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Abstract
Background: Enterohaemorrhagic Escherichia coli (EHEC) is considered to be common cause of
haemorrhagic colitis (HC), thrombotic thrombocytopenic purpura and haemolytic uraemic
syndrome (HUS) in humans. In a previous paper, we have demonstrated that EHEC are commonly
found in the intestines of livestock. Infections in humans are, in part, a consequence of consumption
of undercooked meat or raw milk. Argentina has one of the highest records of HUS (300–400
cases/year; 22/100,000 children under 4 years of age). The aim of this work is to communicate the
first isolation of O145:H-from cattle in this country and characterize the virulence cassette,
providing useful information to evaluate the risk of foodborne transmission of this emergent non-
O157:H7 serotype.
Results: EHEC O145:H- was isolated from cattle in an Argentinian feedlot. Pheno- and genotype
of nine strains were characterized, corresponding to several virulence cassettes: VT2+eaeA+ Mp+
(n = 5), VT2+eaeA+ (n = 1), VT1+eaeA+ Mp+ (n = 2), and VT1+eaeA+ (n = 1). Strains isolated from
the same animal were considered only when they showed a different virulence pattern. The clonal
relationship was studied by RAPD. Strains were distributed in two RAPD profiles, which
corresponded to the presence of either, VT1+ or VT2+ genotype. No difference was detected by
RAPD analysis between Mp+ or Mp- strains.
Conclusions: This was the first isolation of EHEC O145:H- serotype in Argentina enlarging the
list of non-O157:H7 serotypes isolated from cattle in this country by us. All O145:H-strains carried
several virulence factors which allow us to predict their potential ability to develop haemolytic
uraemic syndrome in humans.
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Enterohaemorrhagic Escherichia coli (EHEC) is considered
to be common causes of haemorrhagic colitis (HC),
thrombotic thrombocytopenic purpura, and haemolytic-
uraemic syndrome (HUS) in humans [1,2]. In a previous
paper, we have demonstrated that EHEC are commonly
found in the intestines of livestock, specially young cattle;
and infections in humans are, in part, a consequence of
consumption of undercooked meat or raw milk [3–6].
Several outbreaks have occurred mainly in USA, Canada,
United Kingdom and Japan during the last decade [7–10].
Argentina has one of the highest records of HUS (300–
400 cases/year; 22/100.000 children under 4 years of age).
This rate can be compared with the anual incidence of 2.6/
100.000 in Oregon, 3.0 in King County-Washington, 3 to
5 in Canada, United Kingdom, Chile and Uruguay [11]. In
spite of EHEC strain O157:H7 has been reported as a
cause of HUS in this country [12], this strain does not
seem to be so common in this country as in the USA [11].
We have recently published an extensive list of non-
O157:H7 EHEC serotypes isolated from cattle and foods
in Argentina [13], several of them involved as cause of HC
and HUS in somewhere.
In Europe, eighty percent of the VTEC isolated from pa-
tients with diarrhoea corresponded to non-O157 sero-
groups such as O26, O91, O103, O111, O113, O128,
O145 [14]. In 1984, Kudoh et al. [15] described the first
outbreak of disease due to E. coli O145:H- in Japan, affect-
ing to 100 children. Beutin et al. [16] have considered this
serotype as a new emergen. Afterthere, several investiga-
tors notified the isolation of this serotype from cattle and
humans in USA, Canada and Belgium [17–22]. Another
serotype, O145:H25, was found associated to HUS cases
in U.K. [19], meanwhile O145:H8 and O145:H28 were
isolated from healthy cattle in Canada [22] and Germany
[23], respectively.
Aside from known differences among the pathogenicity of
VT1, VT2 and its variants, factors that may affect the viru-
lence of EHEC are the ability to cause attaching and effac-
ing lesions (eae gene) in the intestinal mucosa and
possession of a 60 MDa megaplasmid (Mp) [1]. The aim
of this work is to communicate the first isolation of
O145:H- from cattle in this country and characterize the
virulence cassette of several strains, providing useful infor-
mation to evaluate the risk of foodborne transmission of
this non-O157:H7 serotype.
Results and discussion
Nine Shiga toxin-producing Escherichia coli serogroups
and eleven non-typable strains were identified from a
feedlot in Argentina (data no shown). One of them
(O145) corresponded to a serogroup never described be-
fore in this country. All O145 strains were characterized as
H-. This non-O157:H7 serotype (O145:H-) had been pre-
viously involved in haemolytic uraemic syndrome out-
breaks in Japan [15]. The genotype of those strains were
characterized, corresponding to several virulence cas-
settes: VT2+eaeA+ Mp+ (n = 5), VT2+eaeA+ (n = 1),
VT1+eaeA+ Mp+ (n = 2), and VT1+eaeA+ (n = 1). All these
strains were able to ferment sorbitol within 18 h of incu-
bation at 37°C. Strains isolated from the same animal
were considered only when showed a different virulence
pattern.
O145:H- strains were distributed in two RAPD profiles,
which corresponded to the presence of either, VT1+ or
VT2+ genotype (RAPD profiles 2 and 1, respectively). No
difference was detected by RAPD analysis between Mp+ or
Mp- strains (Fig. 1). This fact suggests that would be nec-
essary to carry on RAPD studies by using new primers or
to apply pulse field electrophoresis technique in the study
of clonal relationships.
Figure 1
RAPD profiles generated using primer M13. Lane MW
contains DNA molecular size marker (100 bp ladder,
Promega, Madison, WI).Page 2 of 5
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in (1 or 2), the ability to develop attaching and effacing
phenomenon on enterocyte surface (eaeA gene) and the
expression of an EHEC haemolysin (HlyEHEC), afford the
potential of O145:H- as foodborne emergent human
pathogen. This EHEC non-O157:H7 serotype, isolated
from cattle in feedlot, was never found by us from grazing
cattle in Argentina [13]. Our finding, and the high inci-
dence rate of HUS in this country, put local health service
authorities on guard.
Conclusions
This was the first isolation of EHEC O145:H- serotype
from Argentinian cattle which enlarges the list of non-
O157:H7 serotypes isolated from bovine and ground beef
in this country by us. All O145:H- strains carried several
virulence factors which allow to predict their potential
ability to develop haemolytic uraemic syndrome in hu-
mans. The strains, which had been isolated from different
animal in the same feedlot, conformed two RAPD profiles
based upon their verotoxin subtype, without clonal differ-
ences.
Materials and methods
Sample collection from cattle
Samples were collected from an Argentinian farm. follow-
ing the method described previously [6]. Briefly, 59 beef
cattle, belonging to a feedlot of Pampeana region, were
sampled fortnightly during six months by a single rectal
swab from each animal. The swabs were placed in trans-
port medium and processed immediately at the laborato-
ry.
Bacterial colonies were grown on MacConkey agar incu-
bating for 24 hs at 37°C. An aliquots of confluent growth,
aproximately 100 colonies, was inoculated into Luria-Ber-
tani broth for 3 h at 37°C and processed for DNA extrac-
tion [6,24]. One ml from each culture was frozen at -70°C
with the addition of glycerol for further isolation of indi-
vidual VT+ colonies (50 to 100 colonies/sample) on a
MacConkey agar plate. Microorganisms were confirmed
as E. coli by means of biochemical test such as citrate, in-
dole, urease and TSI profile.
Detection of VT1, VT2, eae and 60 MDa plasmid by PCR
Escherichia coli growth and DNA preparation were per-
formed as described previously [6,24]. Primers eae-1 and
eae-2 were designed to amplify a portion of the eae gene
which is conserved between enteropathogenic and enter-
ohaemorrhagic E. coli strains. Primer sequences for VT1,
VT2 and eae were indicated in a previous paper [6]. Mp
primer sequences were: MFS1F 5' ACGATGTGGTTTAT-
TCTGGA 3' and MFS1R 5' CTTCACGTCACCATACATAT 3'
(166 bp amplimer) [25]. Tm were calculated for each
primer using Oligo 4.0 (Primer Analysis Software, Nation-
al BioSciences). Amplification of bacterial DNA was per-
formed in a total volume of 50 µl. A negative control
(reagent blank) was included without addition of sample.
Another control was designed by adding DNA from the
strain lacking VT1, VT2, eae and Mp. Two reference strains
O157:H7 were used as positive controls. The conditions
for the PCR amplification of VT1, VT2, eae and Mp were as
described previously [6,24,25]. Amplified products were
analyzed by submarine gel electrophoresis and UV-tran-
sillumination (300 nm).
Fermentation of sorbitol
Sorbitol MacConkey agar was used to test the VT+ strains
for this condition.
Table 1: Feno-genotypic characteristics of O145:H- strains isolated from cattle.
Serotype Animal & Sample Virulence cassette Virulence 
profile
Lane
VT1 VT2 eaeA Mp
O145:H- 52(1) - + + + 1 1
O145:H- 18(1) - + + + 1 2
O145:H- 27(3) - + + + 1 3
O145:H- 46(3) - + + + 1 4
O145:H- 38(4) - + + + 1 5
O145:H- 27(3) - + + - 2 6
O145:H- 1(1) + - + + 3 7
O145:H- 17(11) + - + + 3 8
O145:H- 1(1) + - + - 4 9
n 3 6 9 7
Lane column indicates positions of RAPD study for each strain in Fig. 1.Page 3 of 5
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O and H antigens were determined by means of a micro-
agglutination technique in tubes and plates described by
Guinée et al.[26] and modified by Blanco et. al.[27] using
all available O (O1 – O175) plus six putative new O anti-
gens (OX176-through OX181) [28] and H (H1 – H56)
antisera [29]. Non-specific agglutinins were removed by
absorption with the corresponding cross-reacting anti-
gens. All VTEC were processed for O serogroup determina-
tion. H serotyping was performed only on those strains
which, having been isolated from the same sample, dif-
fered in either one virulence factor or the O serogroup.
Random amplified polymorphic DNA (RAPD) analysis
Bacteria were grown overnight at 37°C in LB broth with
shaking. An aliquot of the culture was diluted 1/10 in wa-
ter to determine the optical density at 600 nm [39]. For an
optical density value of 0.5, a 500 µl aliquot of the station-
ary-phase culture was centrifuged (2 min at 12,000 × g)
and suspended in 500 µl of bidestilled water. The suspen-
sion was then boiled for 10 min, centrifuged (2 min at
12,000 × g) and the supernatant was stored at -70°C. Five
microliters were used as the template for PCR amplifica-
tion. RAPD was performed in a final volume of 50 µl con-
taining 20 mM (NH4)2SO4, 75 mM Tris-HCl pH 9.0,
0.1% (w/v) Tween 20, 2.5 mM MgCl2, 200 µM each
dNTP, 1 µM primer, 2.5 U Taq DNA polymerase. Three
different primers were evaluated: 1281 [31], 970–11 and
M13 [32], but primers 1281 and 970–11 were not dis-
criminatory.
Amplification was done in a Genius thermal cycler
[Techne (Cambridge) Ltd.] as follows: initial denaturation
at 94°C for 5 min (heating rate 60°C/min), followed by
40 cycles of denaturation at 94°C for 1 min (heating rate
29°C/min), annealing at 50°C for 1 1/2 min (cooling rate
26°C/min) and extension at 72°C for 1 1/2 min (heating
rate 29°C/min). Reaction products (10 µl) were analysed
in a 1.8% agarose gel stained with ethidium bromide.
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